Biomaterial Database

Kaposi's sarcoma after renal transplantation. 2005

Matthew M Edey

UI	MeSH Term	Description	Entries
D007166	Immunosuppressive Agents	Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.	Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D009361	Neoplasm Invasiveness	Ability of neoplasms to infiltrate and actively destroy surrounding tissue.	Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012514	Sarcoma, Kaposi	A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.	Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D013997	Time Factors	Elements of limited time intervals, contributing to particular results or situations.	Time Series,Factor, Time,Time Factor
D016030	Kidney Transplantation	The transference of a kidney from one human or animal to another.	Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D065095	Calcineurin Inhibitors	Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.	Calcineurin Inhibitor,Calcineurin Antagonists,Calcineurin Blockers,Protein Phosphatase 3 Inhibitors,Protein Phosphatase-2B Inhibitors,Inhibitor, Calcineurin,Protein Phosphatase 2B Inhibitors

Related Publications

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

November 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

August 2005, The New England journal of medicine,

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

August 2005, The New England journal of medicine,

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

June 1997, The New England journal of medicine,

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

September 2009, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,

Matthew M Edey

Kaposi's sarcoma after renal transplantation.

February 1987, Transplantation proceedings,

Matthew M Edey

Kaposi's sarcoma after renal transplantation. Case reports.

January 1999, Annals of transplantation,

Matthew M Edey

Kaposi's sarcoma after renal transplantation in Turkey.

October 1998, Clinical transplantation,

Matthew M Edey

Cyclosporine formulation and Kaposi's sarcoma after renal transplantation.

September 2005, Transplantation,